Dietary Supplements Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

Market Trends and Insights

Increased Focus on Preventive Healthcare

Preventive-health priorities support demand by giving consumers a reason to use supplements for ongoing health maintenance. In July 2026, 78% of U.S. adults reported taking at least one supplement for their health.^[1] In a September 2026 Morning Consult poll for the Council for Responsible Nutrition, 52% of U.S. adults said supplements were essential or important to maintaining health and wellness. Taken as separate indicators, widespread use and perceived importance give health-maintenance formulas an audience already familiar with supplement use. The commercial opening is to strengthen health-maintenance offers for existing users, so expansion need not depend entirely on recruiting first-time supplement users.

Supplements Targeting Women Consumers Fueling Growth

Women-focused supplement demand has a concrete clinical-use foundation when a formulation addresses a defined reproductive-health need. The American College of Obstetricians and Gynecologists recommends that most women of reproductive age take a daily supplement containing at least 400 mcg of folic acid to help prevent neural tube defects. Exact dosing is determined through shared decision-making between the patient and their obstetrician-gynecologist. This gives manufacturers a product-design brief built around a specified nutrient, daily use, and a defined female population.

Growing Preference for Clean-label, Plant-based and Vegan Formulas

Plant-based supplements can be developed as a pharmacy-facing health proposition, giving ingredient origin and retail access separate roles in the offer. In Opinion’s May 2025 survey for Forbrukerrådet, 48% of 199 Norwegian respondents who bought plant-based supplements in the previous year reported pharmacy purchases, with multiple outlets selectable. In the same buyer group, 20% cited better health generally in responses coded by the survey. These findings connect an observed purchase route with a stated health-maintenance motive, creating a specific context for explaining what a plant-derived formulation is intended to provide. A supplier pursuing these Norwegian buyers can prioritize pharmacy distribution and explain the formulation’s health-maintenance role at that point of sale.

Healthy-aging Focus Accelerating Multivitamin Uptake Among Consumers

Low energy intake offers a specific dietary basis for healthy-aging multivitamin products. Norwegian dietary guidance summarized by the Norwegian Institute of Public Health (FHI) recommends multivitamin/mineral supplements for people with low energy intake, a group that often includes older adults, or with an unvaried diet. This conditional recommendation gives a combined product a role in addressing several nutritional needs through one purchase. Suppliers can build a life-stage variant around that dietary situation, translating broad aging-well positioning into a specific formulation brief. A range organized around dietary needs can distinguish a low-intake multivitamin offer from a general adult product.

Presence of Counterfeit Products Hampering the Growth

Counterfeit supplements create a competitive problem that combines ingredient failure with demand for cheaper alternatives. South Korea’s Trademark Police seized approximately 8,000 counterfeit health and dietary supplement items in 6 raids from July 2025 through January 2026.^[2] Seized products included vitamins, probiotics, and joint and bone supplements with none of their advertised active ingredients. Among 75 UK respondents who knowingly purchased counterfeit food supplements in 2025, 49% said they would buy a similar cheaper-brand product if counterfeits were unavailable.^[3] For legitimate suppliers, these findings imply that product authenticity and price address different parts of the competitive threat. Demonstrating genuine ingredients can distinguish an offer, but it leaves the cost of competing for explicitly price-sensitive counterfeit buyers unresolved.

Rising Consumer Skepticism Toward Synthetic Additives and Mega-dose Safety Concerns

Higher-dose DHA formulas face a commercial constraint when long-term safety has not been established at the proposed intake. In its December 15, 2025 opinion, the European Food Safety Authority (EFSA) concluded that long-term bleeding safety for supplemental DHA alone above 1 g/day could not be established for any population group. It retained 1 g/day as a safe level of intake and did not establish a tolerable upper intake level. For a manufacturer considering a higher-dose DHA formula, this leaves a substantiation problem between increasing the dose and presenting a persuasive long-term safety proposition. Dose escalation in DHA products consequently carries an unresolved development burden, limiting the commercial case for using higher intake as a stand-alone product advantage.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Dietary Supplements Market Segment Analysis

Vitamins accounted for a 26.8% share of the dietary supplements market size in 2026, making them the largest segment. In 2025, Haleon expanded Centrum Daily Kits across Asia-Pacific and reported over 1 million packs sold since launch. The kits provide a 30-day supply of vitamins tailored to gender and age needs. Haleon also reported that the range delivered market-share gains, indicating that these tailored vitamin kits were winning business in the region.

Prebiotic and probiotic supplements are the fastest-growing segment, with a forecast CAGR of 9.85% from 2027 to 2032. BioGaia sold 715 million doses of its branded finished probiotic products worldwide in 2025, defining a dose as the product-specific recommended intake per occasion. That dose volume comes from branded finished products sold to consumers worldwide, with probiotic cultures supplied to a limited number of business customers as a further source of doses beyond that count. H&H International reported that its combined pediatric probiotic and kids’ nutritional supplements sales in mainland China turned around to 2% growth in 2025, helped by portfolio expansion into products such as kids’ nutrition powders. Protein and amino acid supplements serve athletic-performance buyers, illustrated by Glanbia’s broader Performance Nutrition segment, including protein powders and ready-to-drink and ready-to-eat products, which grew like-for-like revenue 2.8% in 2025.

Capsules and softgels represented a 37.75% dietary supplements market share in 2026, making them the largest segment. In May 2026, Robinson Pharma reported 36 softgel encapsulation machines at its flagship facility, including 15 dedicated to vegetarian softgels. Robinson Pharma is a dietary-supplement contract manufacturer, giving brands an external production route to that installed base. A brand can offer a vegetarian softgel through this production model, extending its formulation choices while retaining the leading dosage form.

Gummies are the fastest-growing segment, with a forecast CAGR of 12.25% from 2027 to 2032. In May 2025, Pharmavite opened a New Albany, Ohio, facility that expanded Nature Made vitamin-gummy production and was already producing products ready for sale. The project also supported research and innovation capabilities for vitamin gummies through Pharmavite’s Gummies Innovation Center of Excellence. The facility represented a USD 250 million investment, showing the capital Pharmavite committed to commercial production in the fastest-growing form.

Synthetic/fermentation-derived supplements were the largest segment, accounting for 55.4% of market revenue in 2026. In April 2025, Zhejiang NHU reported annual capacity of 45,000 metric tons for water-soluble vitamin C from its bio-fermentation project in China. This illustrates industrial scale at the ingredient stage, where a specified vitamin input can support development of finished-product formulations. The annual capacity indicates potential vitamin C supply from one fermentation project, leaving actual availability to formulators dependent on production.

Plant-based supplements are the fastest-growing segment, with a forecast CAGR of 10.05% from 2027 to 2032. In May 2025, 20% of 1,001 Norwegian adults reported using supplements made from plant extracts, herbs, or other natural ingredients during the previous year. This established consumer base gives manufacturers a defined audience for plant-origin positioning without requiring every formulation to serve the same health purpose. Animal-based supplements offer another source option, with fish oil and krill oil among the examples in the omega-oil category used for health by 25% of U.S. adults in July 2026.

Women were the largest segment, accounting for 33.86% of market revenue in 2026. In July 2026, 82% of U.S. women reported using at least one supplement for their health, compared with 74% of men. The same survey found vitamin or mineral use among 72% of U.S. women. A women-focused vitamin range can therefore address an audience familiar with the category, giving suppliers a more specific entry proposition than female supplement use alone.

The kids/children segment is forecast to grow fastest, with a CAGR of 11.25% from 2027 to 2032. In mainland China, online channels’ contribution to H&H International’s pediatric probiotic and kids’ nutritional supplement sales rose from 49.2% in 2024 to 62.1% in 2025. That mix shift gives manufacturers of children’s supplements a concrete reason to develop an online route alongside the product itself. Men represent another consumer group, with 30% of U.S. men reporting protein-supplement use for health in July 2026.

General health and wellness was the largest segment, accounting for 40.53% of market revenue in 2026. In a 2025 survey of 6,000 adult vitamin- or mineral-supplement purchasers in Belgium, Germany, Italy, Poland, and Sweden, 63% selected support for overall health as a reason for use. That finding makes broad health maintenance a concrete buyer proposition within a defined supplement-purchasing population.

Immunity enhancement is the fastest-growing segment, with a forecast CAGR of 9.65% from 2027 to 2032. Colostrum sales in SPINS’s natural-channel immune-health category rose 203.4% to nearly USD 4 million in the 52 weeks ending November 30, 2025. This combines a rapidly expanding ingredient proposition with a narrowly defined retail application, giving manufacturers a specific commercial case to examine within the broader immunity offer. Bone and joint health supplements address another distinct application, with 44% of 1,441 qualified respondents in KPMG’s February-March 2026 U.S. survey reporting regular consumption.

Online retail channels were the largest segment, with 27.18% of market revenue in 2026, and the fastest-growing segment, with a projected CAGR of 13.25% from 2027 to 2032. In 2025, iHerb fulfilled more than 44 million orders and served 15 million active customers across its broader health and wellness assortment, including vitamins, minerals, and supplements. That scale can give a supplement supplier access to a large retail platform whose order base extends across related health categories.

iHerb’s AutoShip & Save subscriptions increased 370% in 2025 compared with 2024 across its broader assortment. Separately, iHerb’s Subscribe & Save service lets customers choose delivery frequency for eligible products and add or remove items, skip deliveries, or cancel at any time. The service covers most products shippable to the United States, Singapore, Hong Kong, Korea, and Japan. Customer-selected intervals create a route to scheduled repeat demand, while skips and cancellations keep repeat revenue dependent on continued customer participation.

Geography Analysis

Asia-Pacific Dietary Supplements Market

Asia-Pacific accounted for a 49.55% share of the dietary supplements market size in 2026, making it the largest geography. In 2025, Herbalife reported USD 1.73 billion in net sales across its broader nutrition-products portfolio in its Asia Pacific reporting region, which excludes China, up 0.3% from 2024. Herbalife distributes and markets its nutrition products through a global network of independent members using a direct-selling model. An entrant in these markets therefore faces a sizable incumbent with member relationships, even though Herbalife’s regional sales expanded only modestly.

Middle East and Africa Dietary Supplements Market

Middle East and Africa is the fastest-growing geography, with a forecast CAGR of 8.1% from 2027 to 2032. In September 2025, Aster DM Healthcare’s myAster platform expanded 24/7 express delivery of medicines, health supplements, and beauty products from Dubai to Abu Dhabi, Sharjah, Ajman, and Ras Al Khaimah in the United Arab Emirates. For supplement suppliers, this completed expansion illustrates a route into additional local markets through a service that combines pharmacy fulfillment with a broader health-products assortment.

In North America, 31% of U.S. adults reported taking protein supplements, including powders, drinks, or bars, for health in July 2026. In Europe, 34% of vitamin- or mineral-supplement users surveyed in Belgium, Germany, Italy, Poland, and Sweden in 2025 reported recommendations from healthcare practitioners, including doctors and nurses. In South America, Brazil required Anvisa notification by September 1, 2026 for transition-covered supplements communicated to local health authorities by August 31, 2024. Qualifying products in Brazil manufactured by September 1, 2026 may be sold through expiration even without that notification. The exception lets a Brazilian supplier manage eligible existing batches separately from notification regularization, instead of treating the deadline as an automatic withdrawal date.

Regulatory Framework and Outlook

The comparison examines selected jurisdictions from the perspective of an established manufacturer introducing a compliant finished-supplement range. It contrasts manufacturing procedures, product notification, registered health-food entry, constituent eligibility, and low-risk health-supplement claims. The China column covers the registered health-food route, while the South Africa column covers SAHPRA-defined health supplements. Attractiveness reflects how these duties affect the manufacturer’s ability to supply and differentiate that range.

For an established manufacturer, Medium attractiveness and No change in the United States and Germany reflect manufacturing-procedure duties and notification without product approval, respectively. China’s registered health-food route supports Medium attractiveness through 5-year certificates, while December 1, 2026 outsourcing rules combine contractor-supervision duties with alternative authorization routes for commissioning certificate holders, supporting No change overall. Brazil’s April 22, 2026 turmeric-supplement update places an ingredient-specific change within its constituent-limit framework, supporting Medium attractiveness and No change for a manufacturer meeting applicable formulation and labeling duties. South Africa’s low-risk framework supports Medium attractiveness and No change because covered complementary medicines may stay on sale only with a registration application filed by the applicable call-up deadline, relevant operators holding section 22C(1)(b) licenses within specified timeframes, compliance with section 20, regulations 10, 11, 12 and 42 and other applicable provisions, and low-risk indications.

Value Chain Stages

The value chain compares ingredient licensing, supplement manufacturing, and finished-product distribution through the capabilities each stage supplies and the revenue it can capture. Niagen Bioscience offers licensing for its patented Niagen nicotinamide riboside ingredient, while Robinson Pharma provides supplement contract manufacturing across multiple forms. These distinct roles let a brand combine specialized inputs with external production capacity, making coordination between the formulation and the manufacturing agreement commercially significant.

In 2025, iHerb opened fulfillment centers in Dallas-Fort Worth and Riyadh, Saudi Arabia, to improve delivery speed, reliability, and cost efficiency across its broader health and wellness business. iHerb stocks products from manufacturers and authorized distributors, placing retail assortment and fulfillment within the same downstream stage. The expansion puts delivery execution at retailer-operated sites, giving supplement brands access to fulfillment investment they do not have to own.

Key Opportunities for Market Participants

The opportunities compare differentiated supplement development with country-specific preparation for finished-product market access. On October 19, 2026, the U.S. Food and Drug Administration finalized nonbinding guidance on recommended identity and safety information for new dietary ingredient notifications. For manufacturers developing supplements containing these ingredients, the planning opportunity lies in linking product development to a sufficiently defined evidence package before commercial introduction.

Indonesia’s announced extension would give manufacturers a preparation window, while Brazil’s continuing technical duties place stability evidence alongside regularization. A manufacturer can use these planning points to develop a finished-product proposition whose formulation and documentation advance together. For affected Brazilian legacy ranges, dossier completion is the immediate opening because notification regularization leaves stability, quality, and safety obligations in place.